Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal Nov. 1, 2011 By Glen Harris No Comments No AbstractRead More
Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline Nov. 1, 2011 By Glen Harris No Comments No AbstractRead More
PDL Divestiture Continues in $170M Deal with EKR Nov. 1, 2011 By Glen Harris No Comments No AbstractRead More
Phenomix Seeking $86M IPO to Push Diabetes Candidate Nov. 1, 2011 By Glen Harris No Comments No AbstractRead More
Regeneron Signs Another Deal For A Potential $120M Payoff Nov. 1, 2011 By Glen Harris No Comments No AbstractRead More
Arginetix, Immune Control Merge Two Corridors in Vascular Space June 18, 2010 By Glen Harris No Comments
Alvine Brings in Another $21M to Fund Celiac Disease Studies Sep. 16, 2009 By Glen Harris No Comments
NPS Boosts Treasury with $40M Equity Financing for Pivotal Trials Aug. 7, 2009 By Glen Harris No Comments
